An effective and considerable treatment of pilonidal sinus disease by laser ablation.
Zhicheng Li, Lei Jin, Tianyun Gong...
https://pubmed.ncbi.nlm.nih.gov/36856904/Actively Recruiting
Led by Mersin University · Updated on 2026-07-21
64
Participants Needed
1
Research Sites
4 weeks
Total Duration
Pilonidal sinus disease is a common infection occurring in the skin near the tailbone, often affecting men between 20 and 30 years old. This study is observing and comparing two minimally invasive treatments for this condition phenolization and laser ablation. Both methods aim to treat symptomatic pilonidal sinus disease, which causes pain, itching, and discharge that affect daily life. The study focuses on evaluating which treatment is better by looking at healing and recovery outcomes. Participants will receive either phenol therapy, where a chemical agent called phenol is applied to the sinus tract to encourage healing, or laser ablation, which uses laser energy to destroy the sinus tract. These treatments are for patients with uncomplicated pilonidal sinus disease. Data collection will take place between November 2024 and November 2025, including follow-up visits after treatment on days 1 and 7, and again at 6 and 12 months. During the study, researchers will collect information from medical records and patient interviews, including pain scores shortly after treatment, wound complications, recurrence rates, hospital stay length, and time to return to normal activities. Follow-up assessments will monitor these outcomes up to one year after treatment. At least 64 patients will be included, divided between the two treatment groups, to compare their results and determine which minimally invasive approach may be preferable.
CONDITIONS
Phenol or Laser: Best Minimally Invasive Treatment for Pilonidal Sinus?
H
Hilmi Bozkurt, Assoc Prof
D
Doğuş Parlak, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mersin University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 year
Participants receive either phenol therapy or laser ablation for pilonidal sinus disease as decided with their doctor.
Follow-up visits on days 1, 7, 6 months, and 12 months after treatment
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Zhicheng Li, Lei Jin, Tianyun Gong...
https://pubmed.ncbi.nlm.nih.gov/36856904/A A Pronk, N Smakman, E J B Furnee
https://pubmed.ncbi.nlm.nih.gov/31278458/Jordi Elvira Lopez, Jorge Escuder Perez, Ricard Sales Mallafre...
https://pubmed.ncbi.nlm.nih.gov/36700412/Veysi Hakan Yardimci
https://pubmed.ncbi.nlm.nih.gov/32064640/Ivan Romic, Goran Augustin, Branko Bogdanic...
https://pubmed.ncbi.nlm.nih.gov/34291332/Mersin University
Lead Sponsor